Tilia Fe Kit
Product Images NDC 75907-086

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Tilia Fe (NDC 75907-086). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy�s Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

FDA Label Image

Fig1 (Fig1(1))

FDA Label Image

Fig2 (Fig2(1))

Figure 2 shows the mean percent reduction in total lesion counts from baseline to each 28-day cycle and the mean total lesion counts at each cycle following the administration of norethindrone acetate and ethinyl estradiol (NDAc/EE) tablets and placebo. Statistically significant differences were not found in both studies individually until cycle 6. The table displays the baseline and cycle-wise mean total lesion counts for the NDAc/EE tablets group and the placebo group.*

FDA Label Image

Fig3 (Fig3(1))

Figure 3 shows the mortality rates per 100,000 woman years based on age, smoking status, and combined oral contraceptive use. The text in the figure is not readable.*

FDA Label Image

Fig4 (Fig4(1))

FDA Label Image

Fig5 (Fig5)

This text appears to be describing a set of starter pills for a menstrual cycle tracking system. The text mentions different colored tablets, such as pale yellow, light yellow, and light brown, indicating different stages of the cycle. It also includes instructions to start the pill pack based on the first day of the period, and a directive to take pills in a left to right direction.*

FDA Label Image

Fig6 (Fig6)

ANNUAL NUMBER OF BIRTH-RELATED OR METHOD-RELATED DEATHS ASSOCIATED WITH CONTROL OF FERTILITY PER 100,000 NONSTERILE WOMEN, BY FERTILITY CONTROL METHOD ACCORDING TO AGE. This text provides data on the number of deaths related to birth or method of fertility control per 100,000 nonsterile women, categorized by age. It includes information on various methods of fertility control such as no method, oral contraceptives for non-smokers and smokers, condoms, diaphragms with spermicide, and periodic abstinence. The text also clarifies that some deaths are birth-related while others are method-related.*

FDA Label Image

Table1 (Table1)

FDA Label Image

Table4 (Table4)

Table 4 provides the annual number of birth-related or method-related deaths associated with control of fertility per 100,000 nonsterile women, categorized by fertility control method and age group. The table includes data for different methods such as no fertility control methods, oral contraceptives for non-smokers and smokers, condom usage, diaphragm/spermicide usage, and periodic abstinence. The table also indicates whether the deaths are birth-related or method-related. However, the source of this information is not provided.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.